2022-11-11T20:00:17-06:00 2021-12-31 366055558 GRANT THORNTON LLP 1000 WILSON BLVD SUITE 1400 ARLINGTON VA 22209 990 2021-01-01 237311318 DRUG INFORMATION ASSOCIATION INC DRUG 2154426100 21 DUPONT CIRCLE NW SUITE 300 WASHINGTON DC 20036 JACK FOSTER CFO 2026018900 2022-11-11 1 JACK FOSTER 999009999 MARY TORRETTA P00847851 7038477500 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z BARBARA LOPEZ KUNZ 21 DUPONT CIRCLE NW SUITE 300 WASHINGTON DC 20036 20903518 0 X WWW.DIAGLOBAL.ORG X 1964 MD SEE SCHEDULE O 13 13 58 2500 210078 34343 0 2158372 13634198 13741802 271596 672431 5000000 2360205 18905794 18932810 220 0 0 0 9813726 8625908 0 0 0 9208908 8718987 19022854 17344895 -117060 1587915 19738468 19118250 11860341 9244513 7878127 9873737 X SEE SCHEDULE O 0 0 9542093 996244 DIA PROVIDES PROGRAMS TO DEVELOP, STRENGTHEN, AND SUPPORT COLLABORATION WITH POLICY MAKERS, INDUSTRY REPRESENTATIVES, PUBLIC HEALTH AUTHORITIES, ACADEMIA AND OTHER HEALTHCARE STAKEHOLDERS. 2895209 8668424 SEE SCHEDULE O 1074252 3393616 SEE SCHEDULE O 249482 683518 PUBLICATIONS: THERAPEUTIC INNOVATION & REGULATORY SCIENCE PUBLICATION (TIRS) IS THE OFFICIAL JOURNAL OF DIA. ITS MISSION IS TO ADVANCE HEALTHCARE PRODUCT DISCOVERY, DEVELOPMENT, REGULATION, AND USE THROUGH THE PUBLICATION OF PEER-REVIEWED ARTICLES AND COMMENTARIES ACROSS THE SPECTRUM OF CONVERTING BIOMEDICAL SCIENCE INTO PRACTICAL SOLUTIONS TO ADVANCE HUMAN HEALTH. IT IS PUBLISHED IN ODD NUMBER MONTHS, JANUARY, MARCH, MAY, JULY, SEPTEMBER, AND NOVEMBER. DIA ALSO PUBLISHES THE GLOBAL FORUM, ANOTHER E-PUBLICATION. IT OFFERS EXPERT GLOBAL AND REGIONAL COVERAGE OF DISCOVERY, DEVELOPMENT, REGULATION, SURVEILLANCE, AND MARKETING OF HEALTHCARE PRODUCTS, INCLUDING INTERVIEWS WITH LEADERS AND TOPICAL SUMMARIES FROM EDUCATIONAL EVENTS. IT IS PUBLISHED MONTHLY. 249482 683518 13761036 1 1 0 0 0 0 0 0 0 0 1 0 0 1 0 1 0 1 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 72 0 1 58 1 1 1 1 CH IN JA SZ 0 0 0 0 0 0 0 0 0 0 X 13 13 0 0 0 0 1 0 0 1 1 0 1 1 0 1 1 1 1 1 1 1 0 X ANNE MARIE LOGUE CPA DIRECTOR FI 2026018900 21 DUPONT CIRCLE NW SUITE 300 WASHINGTON DC 20036 MICHAEL ROMANO TREASURER/SECRETARY 2.50 0.00 X X 0 0 0 JUDITH NG-CASHIN CHAIR 2.50 0.00 X X 0 0 0 CYNTHIA VERST CHAIR ELECT 1.25 0.00 X X 0 0 0 MICHAEL DEVOY MEMBER 1.25 0.00 X 0 0 0 ELIZABETH GARNER MEMBER 1.25 0.00 X 0 0 0 PETER HONIG MEMBER 1.25 0.00 X 0 0 0 ANGELIKA JOOS MEMBER (END 06/21) 1.25 0.00 X 0 0 0 FRANK JIANG MEMBER 1.25 0.00 X 0 0 0 TATYANA KOSHELEVA MEMBER 1.25 0.00 X 0 0 0 MICHAEL ROSENBLATT MEMBER 1.25 0.00 X 0 0 0 JONATHAN SHELDON MEMBER (END 06/21) 1.25 0.00 X 0 0 0 PETER SORGER MEMBER 1.25 0.00 X 0 0 0 LINGSHI TAN PAST CHAIR 2.50 0.00 X 0 0 0 KIHITO TAKAHASHI MEMBER 1.25 0.00 X 0 0 0 KARIN VAN BAELEN MEMBER 1.25 0.00 X 0 0 0 REBECCA VERMEULEN PAST CHAIR (END 06/21) 2.50 0.00 X 0 0 0 BARBARA LOPEZ KUNZ GLOBAL CHIEF EXECUTIVE 40.00 0.00 X 831686 0 34644 VIVIANNA GUZMAN CHIEF FINANCIAL OFFICER(02/21-12/21) 40.00 0.00 X 280174 0 14852 ANIA MITAN SVP/MANAGING DIR, EMEAIS 40.00 0.00 X 286724 0 25234 TIM HESS VICE PRESIDENT, IT 40.00 0.00 X 238605 0 35446 WILLIAM ALLMAN CHIEF DIGITAL OFFICER (END 05/21) 40.00 0.00 X 175856 0 14080 ROBIN WEINICK SVP/MANAGING DIR, AMERICAS(END 5/21) 40.00 0.00 X 175417 0 11797 CATHY PERSIDIS ASSOCIATE DIR, EMEA OPERATIONS 40.00 0.00 X 189824 0 11570 OZGUR KARA REGIONAL ASSOC. DIR, EMEA FINANCE 40.00 0.00 X 183041 0 14266 LINDA HEE JUNG KO ASSOCIATE DIR, BUS DEVELOPMENT 40.00 0.00 X 161079 0 31407 ALEXANDER ELDRIDGE SENIOR IT PROJECT MANAGER 40.00 0.00 X 161754 0 28010 KATIE TRUONG DIRECTOR, PEOPLE OPERATIONS 40.00 0.00 X 159111 0 24872 2843271 0 246178 25 0 1 0 RSM 5155 PAYSPHERE CIRCLE CHICAGO IL 60674 ACCOUNTING SERVICES 436834 COVR KLEINHOEFSTRAAT 11/2 GEEL BE AUDIO VISUAL SERVICES 323397 SHUFFLE LABS 13800 COPPERMINE RD STE 239 HERNDON VA 20171 IT CONSULTING SUPPORT SERVICES 245250 SMITHBUCKLIN CORPORATION 8318 SOLUTIONS CENTER CHICAGO IL 606778003 EXHIBIT SALES COMMISSIONS 231076 GRANT THORNTON 33960 TREASURY CENTER CHICAGO IL 606943900 AUDIT AND TAX SERVICES 201508 9 2158372 2158372 MEETINGS AND WORKSHOPS 611710 8668424 8668424 TRAINING 611710 3393616 3393616 MEMBERSHIP DUES 900099 996244 996244 PUBLICATIONS 900004 408518 198440 210078 TUFTS RESEARCH PROJECT 900099 275000 275000 13741802 245019 245019 2385786 12334 1955558 15150 430228 -2816 427412 427412 INSURANCE RECOVERY 900099 2355205 2355205 KNOWLEDGE BRIGADE REVENUE 900099 5000 5000 2360205 18932810 13531724 210078 3032636 2124515 1593386 531129 5489943 4117457 1372486 321979 241484 80495 535983 401987 133996 153488 115116 38372 266456 199842 66614 926807 695105 231702 67486 67486 1487087 1201592 285495 235261 175927 59334 422312 316734 105578 959720 719790 239930 93449 41788 51661 43195 32396 10799 448543 336408 112135 101683 76262 25421 MEETING COSTS 2517453 2517453 TRAINING & E-LEARNING 591452 591452 DUES AND SUBSCRIPTIONS 152187 114140 38047 PUBLICATION COSTS 126794 126794 279102 145923 133179 17344895 13761036 3583859 0 8151662 2927590 350919 1008073 1118714 849898 2420925 1995346 782495 425579 8145238 12525487 1189440 1381623 19738468 19118250 6109962 2796959 1692007 3447554 3000000 3000000 1058372 0 11860341 9244513 X 7878127 9654789 218948 7878127 9873737 19738468 19118250 X 1587915 460402 -52707 X 0 1 X 1 0 X 2158372 2158372 22171029 23320631 23618071 13634198 13531724 96275653 22171029 23320631 23618071 13634198 15690096 98434025 0 0 0 98434025 792626 355266 296267 198767 245019 1887945 14871 42676 24410 5851 35343 123151 807497 397942 320677 204618 280362 2011096 -74607 -74607 -26385 5000000 2360205 7333820 22903919 23692188 23938748 18838816 18330663 107704334 0.91390 0.93340 0.01870 0.02310 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2017 AMOUNT: $ 0. 2018 AMOUNT: $ -26,385. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 5,000,000. 2021 AMOUNT: $ 2,360,205. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 381754 338044 43710 1732903 1387649 345254 306268 269653 36615 425579 DUE FROM AFFILIATES 1344781 TENANT SECURITY DEPOSITS 36842 1381623 X PART X, LINE 2: ASC 740 (FIN48) FOOTNOTE THE ASSOCIATION HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 1 18 PROGRAM SERVICES MEETINGS & TRAININGS 4249275 SOUTH ASIA 1 2 PROGRAM SERVICES MEETINGS & TRAININGS 80054 EAST ASIA AND THE PACIFIC 2 16 PROGRAM SERVICES MEETINGS & TRAININGS 5393097 4 36 0 0 4 36 9722426 0 9722426 0 0 1 0 0 0 PART III ACCOUNTING METHOD: X X X X 1 0 0 0 0 0 0 1 0 BARBARA LOPEZ KUNZ GLOBAL CHIEF EXECUTIVE 586541 0 233818 0 11327 0 17400 0 17244 0 866330 0 0 0 ANIA MITAN SVP/MANAGING DIR, EMEAIS 275000 0 11724 0 0 0 25234 0 0 0 311958 0 0 0 VIVIANNA GUZMAN CHIEF FINANCIAL OFFICER(02/21-12/21) 263836 0 0 0 16338 0 8065 0 6787 0 295026 0 0 0 TIM HESS VICE PRESIDENT, IT 199815 0 31244 0 7546 0 12846 0 22600 0 274051 0 0 0 CATHY PERSIDIS ASSOCIATE DIR, EMEA OPERATIONS 172000 0 17824 0 0 0 11570 0 0 0 201394 0 0 0 OZGUR KARA REGIONAL ASSOC. DIR, EMEA FINANCE 169782 0 13259 0 0 0 14266 0 0 0 197307 0 0 0 LINDA HEE JUNG KO ASSOCIATE DIR, BUS DEVELOPMENT 158741 0 0 0 2338 0 4422 0 26985 0 192486 0 0 0 WILLIAM ALLMAN CHIEF DIGITAL OFFICER (END 05/21) 105594 0 25000 0 45262 0 6965 0 7115 0 189936 0 0 0 ALEXANDER ELDRIDGE SENIOR IT PROJECT MANAGER 145487 0 13137 0 3130 0 9308 0 18702 0 189764 0 0 0 ROBIN WEINICK SVP/MANAGING DIR, AMERICAS(END 5/21) 130186 0 0 0 45231 0 8319 0 3478 0 187214 0 0 0 KATIE TRUONG DIRECTOR, PEOPLE OPERATIONS 145544 0 12617 0 950 0 8746 0 16126 0 183983 0 0 0 PART I, LINE 4A: SEVERANCE PAYMENTS THE AMOUNT OF SEVERANCE PAID AND INCLUDED IN PART II, COLUMN B (III) ARE AS FOLLOWS: VIVIANNA GUZMAN $12,500; WILLIAM ALLMAN $29,557 AND ROBIN WEINICK $30,288. PART I, LINE 7: NON-FIXED PAYMENTS CERTAIN EMPLOYEES ARE ELIGIBLE FOR DISCRETIONARY BONUSES CONTINGENT ON MEETING INDIVIDUAL PERFORMANCE METRICS DURING THE YEAR AND THE ORGANIZATION'S GOALS AS A WHOLE. BONUSES ARE CONSIDERED ALONG WITH OTHER COMPENSATION TO ENSURE THAT ALL COMPENSATION PAYMENTS ARE REASONABLE. FORM 990, PART I, LINE 1 AND PART III, LINE 1 DRUG INFORMATION ASSOCIATION, INC. ("DIA") FOSTERS INNOVATION TO IMPROVE HEALTH AND WELLBEING WORLDWIDE BY: - PROVIDING INVALUABLE FORUMS TO EXCHANGE VITAL INFORMATION AND DISCUSS CURRENT ISSUES RELATED TO HEALTH PRODUCTS, TECHNOLOGIES, AND SERVICES; - DELIVERING CUSTOMIZED LEARNING EXPERIENCES; - BUILDING, MAINTAINING, AND FACILITATING TRUSTED RELATIONSHIPS WITH AND AMONG INDIVIDUALS AND ORGANIZATIONS THAT DRIVE AND SHARE DIA VALUES AND MANDATES; AND - OFFERING A MULTIDISCIPLINARY NEUTRAL ENVIRONMENT, RESPECTED GLOBALLY FOR INTEGRITY AND RELEVANCY. FORM 990, PART III, LINE 4B PROGRAM SERVICE ACCOMPLISHMENT 2 IN 2021 DIA HELD MORE THAN 150 MEETINGS, WORKSHOPS AND TRAININGS WORLDWIDE, DIA ATTRACTED OVER 10,000 PARTICIPANTS TO MEETINGS, WORKSHOPS AND TRAININGS IN THE UNITED STATES, EUROPE, CHINA, JAPAN, AND INDIA. IN ADDITION TO THESE EVENTS, THE DIA ANNUAL MEETING, THE LEADING GLOBAL CONFERENCE ON PHARMACEUTICAL INFORMATION AND EDUCATION, ATTRACTED OVER 4,476 PARTICIPANTS FROM THE US AND ACROSS THE WORLD THROUGH ITS VIRTUAL PLATFORM. THE ANNUAL DIA EUROPEAN ANNUAL MEETING, WHICH IS RECOGNIZED AS ONE OF THE PREMIER FORUMS FOR THE EXCHANGE OF INFORMATION IN THE EUROPEAN MEDICAL/PHARMACEUTICAL COMMUNITY, ATTRACTED 418 PARTICIPANTS. THE JAPAN ANNUAL MEETING, SINGAPORE ANNUAL MEETING AND CHINA ANNUAL MEETING HAD 538, 145 AND 3,010 PARTICIPANTS RESPECTIVELY. FORM 990, PART III, LINE 4C PROGRAM SERVICE ACCOMPLISHMENT 3 LEARNING: WITH AN ON-GOING COMMITMENT TO INTERNET TECHNOLOGY-BASED LEARNING, DIA CONTINUED TO EXPAND ITS GLOBAL REACH AND ADVANCE ITS MISSION BY OFFERING VARIOUS LEARNING OPPORTUNITIES IN ELECTRONIC FORMAT. IN 2021, DIA HAD 5,413 ELEARNERS INCLUDING BOTH INDIVIDUALS AND GROUPS. IN ADDITION, THERE WERE 55 TRAINING COURSES HELD GLOBALLY WITH 2,797 PARTICIPANTS TRAINED THROUGH THESE ONLINE TRAINING COURSES. FORM 990, PART VI, SECTION A, LINE 6 MEMBERS OR STOCKHOLDERS THE ORGANIZATION HAS MEMBERS WHO PAY DUES BUT HAVE NO OWNERSHIP INTEREST IN THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS IRS FORM 990 IS PREPARED AND REVIEWED BY AN INDEPENDENT ACCOUNTING FIRM. A DRAFT IS THEN JOINTLY REVIEWED BY THE PRESIDENT & GLOBAL CHIEF EXECUTIVE, THE CFO AND THE BOARD TREASURER/FINANCE COMMITTEE CHAIR. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY MONITORING AND ENFORCEMENT PERIODICALLY, MANAGEMENT EVALUATES EXISTING PAID VENDOR RELATIONSHIPS FOR GOODS AND/OR SERVICES. THEY ASSESS THE PARTIES INVOLVED AND THE RELATIONSHIPS BETWEEN THEM AND DIA. WHERE CONFLICTS WITH STANDING POLICY MAY DEVELOP OR EXIST, APPROPRIATE CORRECTIVE ACTIONS ARE TAKEN, UP TO AND INCLUDING REPLACEMENT OF THE VENDOR WITH A SUITABLE AND QUALIFIED SUBSTITUTE THAT POSES NO CONFLICT OF INTEREST. NEW VENDORS ARE EVALUATED TO DETERMINE IF POTENTIAL CONFLICTS EXIST BEFORE APPROVAL OF ANY PAID RELATIONSHIP IS GRANTED. EVERY YEAR, ALL BOARD MEMBERS COMPLETE AND SIGN A CONFIDENTIALITY AGREEMENT TO MAINTAIN CONFLICT OF INTEREST POLICY. IF A BOARD MEMBER IS CONFLICTED OR THERE IS A POTENTIAL PERCEIVED CONFLICT, THAT BOARD MEMBER WILL RECUSE THEMSELVES FROM FURTHER DELIBERATIONS AND DECISION-MAKING ON THE MATTER. FORM 990, PART VI, SECTION B, LINE 15 PROCESS USED TO DETERMINE EXECUTIVE COMPENSATION ON A REGULAR BASIS, BUT NO LESS THAN BIENNIALLY, THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS EVALUATES THE COMPLETE COMPENSATION PACKAGES OF ALL UPPER MANAGEMENT LEVEL EMPLOYEES TO ENSURE THEY ARE COMPLIANT WITH ALL APPLICABLE LAWS AND CONSISTENT WITH THE PROVISIONS OF STANDING COMPENSATION POLICY. THIS INCLUDES SALARY, BENEFITS, BONUSES AND OTHER PAYMENTS MADE TO BOTH SENIOR MANAGEMENT AND ALL OTHERS DEEMED TO BE SUBJECT TO COMPENSATION REVIEW. THE COMPENSATION COMMITTEE OBTAINS AND RELIES UPON COMPARABLE DATA IN THE SAME OR SIMILAR COMMUNITIES FOR SIMILAR SERVICES. THE REVIEW PROCESS AND BASIS FOR COMPENSATION PACKAGES IS ADEQUATELY DOCUMENTED. THE RESULTS OF THE EVALUATION ARE PRESENTED TO THE BOARD OF DIRECTORS IN A PERFORMANCE AND COMPENSATION REPORT. FORM 990, PART VI, SECTION C, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION'S BYLAWS ARE AVAILABLE TO THE PUBLIC ON ITS WEBSITE. CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART XI, LINE 9: FOREIGN CURRENCY EXCHANGE LOSS -52,707. DRUG INFORMATION ASSOCIATION LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 237311318 DRUG EDUCATION PA 0 1324927 DIA INC DIA GLOBAL HEALTHCARE LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 237311318 DRUG EDUCATION PA 0 449976 DIA INC DIA LEARNING LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 475438125 DRUG EDUCATION PA 1420395 1256347 DIA INC DIA(INDIA) PRIVATE LIMITED UNIT 250 TIMES SQUAREANDHERI EAST MUMBAI IN 400059 SCIENTIFIC ED IN DIA INC C 130239 94364 1.00000 1 DIA EUROPE GMBH KUECHENGASSE 16 POSTAFACH BASEL SZ 4002 SCIENTIFIC ED SZ DIA INC C -13970 168480 1.00000 1 DIA E-LEARNING EUROPE GMBH KUECHENGASSE 16 POSTAFACH BASEL SZ 4002 SCIENTIFIC ED SZ DIA INC C -331 7322 1.00000 1 DIA (BEIJING) HEALTHCARE INFORMATION GATEWAY PLAZA BEIJING CH SCIENTIFIC ED CH DIA GLOBAL HLTH C 6328139 3507985 1.00000 1 SH DIA JAPAN NIHONBASHI LIFE SCI BLDG 6F TOKYO JA SCIENTIFIC ED JA DIA LLC C 994682 3783764 1.00000 1 DIA (SHANGHAI) HEALTHCARE INFORMATION SHANGHAI SHANGHAI CH SCIENTIFIC ED CH DIA GLOBAL HLTH C 1.00000 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 0 1 1 DIA INDIA R 50424 CASH